Borderline personality disorder (BPD) and bipolar disorder both involve intense mood changes, but they run on different clocks for different reasons. In BPD, mood shifts are reactions, most often to a relationship that suddenly feels threatened, and they usually last hours. In bipolar disorder, mood changes arrive as sustained episodes, at least four days of hypomania or a week of mania, with changes in sleep and energy.^1,2

That difference is the argument of this article. The instability in BPD is driven by attachment threat: an unanswered text, a shift in someone’s tone, the conviction that a person is about to leave. The instability in bipolar disorder is driven by an episodic change in mood, energy and sleep that, once it starts, runs its own course for days or weeks. The two are confused often, and the confusion sends treatment the wrong way. People with BPD collect prescriptions that trials have not shown to treat the core of their problem, while people with bipolar disorder can be steered toward relationship-focused therapy without the medical care that lowers the risk of the next episode.^3,4,2

Two kinds of mood instability

The DSM-5-TR describes BPD as a long-standing pattern of instability in relationships, self-image and emotion, with marked impulsivity. A diagnosis needs at least five of nine criteria.^1,5 Two matter most here: “frantic efforts to avoid real or imagined abandonment,” and affective instability “due to a marked reactivity of mood,” with episodes of dysphoria, irritability or anxiety “usually lasting a few hours and only rarely more than a few days.”¹

Bipolar disorder is defined by episodes. A manic episode is a distinct period of abnormally and persistently elevated, expansive or irritable mood, together with persistently increased activity or energy, present most of the day, nearly every day, for at least a week, or for any length of time if hospitalization is needed. It also requires symptoms such as inflated self-esteem, decreased need for sleep, pressured speech and racing thoughts. Hypomania has the same shape but lasts at least four consecutive days and stops short of marked impairment or psychosis. Bipolar I is defined by at least one manic episode. Bipolar II requires hypomanic and depressive episodes with no history of mania.^1,6

Measured side by side, the two kinds of instability look different. In a 2001 study, patients with BPD swung more between normal mood and anger, while patients with bipolar II swung between normal mood and depression or elation.⁷ A 2012 McLean Hospital study of 29 patients with BPD and 25 with bipolar II or cyclothymia found a similar split: more frequent and intense shifts among anger, anxiety and depression in BPD, more shifts into elation in the bipolar group.⁸ Paris and Black summed up the literature in 2015: BPD brings transient mood shifts in response to interpersonal stress, and bipolar disorder brings sustained mood change.²

That is wrong. In a Pittsburgh study of 39 patients, life events that disrupted daily routines were more common in the eight weeks before a manic episode than in a comparison period.⁹ Stress and disrupted routines can tip someone into an episode. The difference is what happens next. In BPD the mood tracks the relationship and can settle within hours when the threat passes. A bipolar episode keeps going on its own momentum. The 2018 CANMAT/ISBD bipolar guidelines put it plainly: in BPD, “true euphoria and prolonged well-functioning intervals are extremely rare.”⁶

Why the two keep getting confused

Part of the confusion is historical. “Borderline” began as a psychoanalytic word. In 1938 Adolph Stern published a paper on what he called the “border line group of neuroses.”¹³ Otto Kernberg’s 1967 paper described “borderline personality organization.”¹⁴ In 1975 Gunderson and Singer proposed six features for spotting borderline patients in an interview, among them brief psychotic experiences and relationships that “vacillate between transient superficiality and intense dependency.”¹⁵ BPD entered the DSM-III in 1980, and its defining criteria have changed little since.⁵

Then came the mood-spectrum argument. In 2004 Akiskal argued that borderline personality has a “natural kinship with the bipolar spectrum.”¹⁶ Paris argued the opposite the same year: the two differ in phenomenology, family history, long-term course and treatment response, and that the evidence was insufficient to place BPD inside the bipolar spectrum.¹⁷ Later reviews mostly agreed. Zimmerman and Morgan concluded in 2013 that the co-occurrence data “challenge the notion that BPD is part of the bipolar spectrum.”¹⁸ Ghaemi and colleagues found the two alike in mood lability and impulsivity but different on nearly every other test of a diagnosis, including history of sexual abuse, family history of bipolar disorder, self-harm, treatment response and neurobiology.¹¹ Whether BPD is one condition or several is a separate debate, taken up in our post on Theodore Millon and whether BPD is really several disorders, and what DSM categories can and cannot do is the subject of Is the DSM dying?

The confusion also plays out in ordinary clinics, in both directions. In a Rhode Island study of 700 psychiatric outpatients given a structured diagnostic interview, fewer than half of those who said they had been diagnosed with bipolar disorder met criteria for it.¹⁹ An analysis of 610 outpatients by the same research group found that BPD significantly raised the odds of an earlier bipolar misdiagnosis.²⁰ The CANMAT/ISBD guidelines warn about underdiagnosis as well as overdiagnosis, note that BPD, substance use and ADHD symptoms overlap with hypomania, and say screening tools such as the Mood Disorders Questionnaire tend to flag borderline traits and should not be used to make the diagnosis.⁶ The ADHD side of that overlap is covered in our post on bipolar disorder and ADHD.

Sex and gender add a layer. The DSM-IV-TR said BPD is diagnosed “predominantly (about 75%) in females,” but Skodol and Bender concluded that the female majority in clinics is largely a sampling effect, and that the modest evidence for diagnostic bias could not explain so wide a gap.²¹ The NESARC survey of 34,653 American adults found a lifetime BPD rate of 5.9%, with no difference between men (5.6%) and women (6.2%).²² That overall rate is well above the 0.7% to 2.7% range the 2024 review gives for the general adult population, so the sex comparison is more informative than the headline number.⁵

When someone has both

The two conditions do co-occur. A 2016 meta-analysis of 42 studies found BPD in 21.6% of 5,273 people with bipolar disorder, rising to 37.7% in bipolar II, and bipolar disorder in 18.5% of 1,814 people with BPD: roughly one in five either way.²³ Zimmerman and Morgan stressed the other side of the number: in 80% to 90% of cases each disorder is diagnosed without the other, and depression, substance use and PTSD are all more common companions of BPD than bipolar disorder is.¹⁸

According to the CANMAT/ISBD guidelines, personality disorders occur in 42% of people with bipolar disorder (borderline in 16%) and predict poorer treatment response, comorbid borderline personality disorder is associated with suicide attempts, and research on treating the combination is “sparse.”⁶ Ghaemi’s group goes further and suggests that true comorbidity may be less common than often presumed.¹¹

Both conditions carry real suicide risk. About 6% to 7% of people identified with bipolar disorder die by suicide.⁶ In a McLean cohort of 290 inpatients with BPD followed for 24 years, 5.9% died by suicide.²⁴ If you are thinking about ending your life, call or text 988, the Suicide and Crisis Lifeline, or use the local options on our Birmingham crisis resources page.

What the biology shows, and what it does not

Genes. Bipolar disorder is strongly heritable. A British twin study estimated its heritability at 85%.¹² BPD features are moderately heritable: in 5,496 twins from the Netherlands, Belgium and Australia, genes explained 42% of the variation.²⁵ The first case-control genome-wide association study of BPD, with 998 patients and 1,545 controls, found genetic overlap with bipolar disorder (a genetic correlation of 0.28), but the overlap with major depression was twice as large (0.57).²⁶

Early adversity. A 2020 meta-analysis of 97 studies found that, in case-control studies, people with BPD were 13.9 times more likely than non-clinical controls to report childhood adversity (the gap was much smaller in epidemiological samples), and 3.15 times more likely than people with other psychiatric diagnoses.²⁷ Adversity matters in bipolar disorder too. Across 19 studies it was 2.63 times more common than in non-clinical controls, though rates were similar to those in other psychiatric groups.²⁸ So childhood adversity is not unique to BPD, but it is more specific to it. That fits the attachment research. A review of 13 studies found that every one reported a strong link between BPD and insecure attachment, especially the unresolved, preoccupied and fearful types, in which people long for closeness while fearing dependency and rejection.²⁹ For background on how attachment is studied in adults, see our piece on Mary Main’s attachment research.

Brain imaging. A 2016 meta-analysis of 19 functional imaging studies, covering 281 patients with BPD, found more activity in the left amygdala and less in the dorsolateral prefrontal cortex during negative emotional material, plus smaller left amygdala gray matter in structural studies; the amygdala overactivity showed up in medication-free samples but not medicated ones.³⁰ In bipolar disorder, an ENIGMA consortium study of 1,710 patients and 2,594 controls found smaller hippocampal and thalamic volumes and larger lateral ventricles. The effects were small (for the hippocampus, d = −0.23), and the authors asked readers to interpret them with caution.³¹ These are averages across groups, and with effects that small the groups overlap heavily. A 2023 World Psychiatry review of candidate biomarkers across psychiatry, bipolar disorder included, concluded that the overwhelming majority have not proven reliable, valid and useful enough to be adopted clinically.³² For BPD, the 2024 review says the neurobiological underpinnings “remain to be clarified.”⁵

Brain maps and neurofeedback. A 2021 review of 44 EEG studies in BPD, under its ICD-10 name of emotionally unstable personality disorder, found poor consistency in the EEG markers reported and no research at all on EEG neurofeedback for the condition.³³ Amygdala neurofeedback using fMRI is being studied, but a 2025 review judged the evidence for its efficacy in BPD limited, and a sham-controlled multicenter trial was launched to test it.³⁴ A critical review in American Psychologist argued that the benefits reported for EEG neurofeedback in general seem to be driven largely by motivation, expectation and other psychosocial factors.³⁵ No brain map can tell you whether you have BPD, bipolar disorder or both. That is a clinical judgment made from a history and a careful interview.

Why the distinction changes treatment

For BPD, psychotherapy is the treatment of choice.⁵  Marsha Linehan’s 1991 randomized trial of dialectical behavior therapy (DBT) found that chronically parasuicidal women with BPD had fewer and less medically severe self-harm episodes and fewer inpatient days than women in usual community care.³⁶ In a 2006 trial against community therapy by non-behavioral experts, women receiving DBT were half as likely to make a suicide attempt.³⁷ Bateman and Fonagy, who went on to develop mentalization-based treatment, showed in a small 1999 trial that psychoanalytically oriented partial hospitalization outperformed standard psychiatric care.³⁸

The meta-analyses are encouraging but sober. In the 2020 Cochrane review of 75 randomized trials with 4,507 participants, BPD-tailored psychotherapy reduced symptom severity compared with usual treatment (standardized mean difference −0.52, moderate-quality evidence), with no clear evidence that one type beat another; much of the evidence on other outcomes was low quality.³⁹ A 2017 JAMA Psychiatry meta-analysis found psychotherapy effects that were real but small, inflated by risk of bias and publication bias, and unstable at follow-up.⁴⁰ In a Canadian trial, a year of DBT and a year of well-specified general psychiatric management by BPD-experienced psychiatrists produced equal improvement.⁴¹ The 2024 review lists DBT, mentalization-based therapy, transference-focused therapy and schema therapy as supported in randomized trials, none of them superior, and notes that almost half of patients do not respond sufficiently.⁵ The fair summary: structured, BPD-informed therapy helps, no brand owns the result, and there is room to do better.

No medication has been shown to treat the core of BPD. The 2022 Cochrane review of 46 randomized trials found mostly very low-certainty evidence of no difference from placebo on the main outcomes, and concluded that “no pharmacological therapy seems effective in specifically treating BPD pathology.”⁴ In the UK LABILE trial, 276 adults with BPD were randomized to lamotrigine or placebo for a year, and their borderline symptom scores at 52 weeks were nearly identical (11.3 versus 11.5).⁴² Lamotrigine is used in bipolar maintenance treatment,⁶ which is the point: treating BPD’s reactivity as if it were a bipolar mood cycle has not held up in trials. Medication may still be useful for discrete, severe anxiety or depressive symptoms, or for psychotic-like features.⁵ Those decisions belong with a psychiatrist or other prescriber who knows the whole picture.

For bipolar disorder, medication is the foundation. The CANMAT/ISBD guidelines call lithium “the gold standard for maintenance treatment,” effective against both manic and depressive episodes and with some anti-suicidal effect. They recommend psychoeducation for all patients as the first-line psychological treatment, with cognitive behavioral therapy, family-focused therapy and interpersonal and social rhythm therapy as further options. DBT, the most studied therapy for BPD,³⁹ is rated as having insufficient evidence for bipolar maintenance.⁶ Therapy earns its place as an adjunct. A 2021 network meta-analysis of 39 trials with 3,863 participants found that manualized psychotherapy added to medication was associated with fewer recurrences than control treatments (odds ratio 0.56), and that psychoeducation with skills practice in a family or group format was associated with fewer recurrences than the same work done individually.⁴³ Recurrence is the central problem: in the STEP-BD study, 48.5% of patients who recovered had a new episode within two years.¹⁰ Someone with bipolar disorder who gets weekly relational therapy and no psychiatric care is under-treated. None of this is dosing advice, and medication choices need a prescriber.

When both are present, the guidelines are frank that the evidence is thin.⁶ In practice that usually means psychiatric care for the mood episodes and BPD-focused therapy for the relational pattern, run in parallel by clinicians who talk to each other.

Where trauma work, body work and parts work fit

In a German multicenter trial of 193 women with PTSD after childhood abuse who also met at least three BPD criteria, a phase-based program called DBT-PTSD and cognitive processing therapy both produced large improvements in PTSD symptoms, with a small advantage and fewer dropouts for DBT-PTSD.⁴⁴ Trauma processing is possible for many people with borderline features when treatment has enough structure. For bipolar disorder, a pilot trial of EMDR in 20 patients with trauma histories and mild residual mood symptoms found improvements in trauma and mood symptoms after treatment, only partly maintained at 24 weeks.⁴⁵ That is a promising pilot, not proof.

Brainspotting, Somatic Experiencing, Lifespan Integration and Internal Family Systems have no randomized trials in BPD or bipolar disorder that I could find. A 2026 systematic review of DBT, mentalization-based treatment and IFS for BPD with depression or anxiety found no IFS outcome studies to include.⁴⁶ These approaches can be part of trauma work for someone whose diagnosis is clear, whose mood is stable enough and whose safety plan is in place. They are not a substitute for BPD-specific therapy or for psychiatric care of bipolar disorder, and they should not be presented as treatments for either condition.

One of the nine BPD criteria is “transient, stress-related paranoid ideation or severe dissociative symptoms.”¹ Dissociation that comes with stress and passes is different from the distinct identity states of dissociative identity disorder, which we cover in our guide to dissociative identity disorder.

What this looks like in therapy

The first job is the timeline, not the label. A careful assessment asks how long the worst moods last, what happened in the hour before, whether sleep dropped without tiredness, whether others noticed a change in speech or spending, what substances were involved, and who in the family has had mood episodes; the CANMAT/ISBD guidelines stress strict use of criteria and a history that includes first-degree relatives.⁶ A few weeks of a daily mood and sleep chart often settles more than an hour of questions. When bipolar disorder looks likely, the next step is a psychiatric evaluation.

When the instability is attachment-driven, therapy works at the moment of threat. In DBT that means a chain analysis of one specific episode: the trigger, the story the mind told about it, the urge, the action, the aftermath. In mentalization-based work it means slowing down to ask what the other person might actually have been thinking. That matters, because neutral faces give people with BPD the most trouble. A 2013 meta-analysis found their largest recognition deficit was for neutral expressions and suggested they may read emotion into them.⁴⁷ In parts-based work, the panicked state that arrives when a partner goes quiet can be treated as one part of the person, with its own history, rather than the whole self, which leaves room to watch it and choose a response. Some people manage the same fear by appeasing everyone around them, a pattern described in our post on the “nice” trauma response and people-pleasing.

When the instability is episodic, therapy looks different. It protects sleep and daily routines, because disrupted routines can precede mania.⁹ It builds an early-warning plan with the person and, ideally, with family, and it supports the medication plan rather than competing with it.^6,43

For someone with both, the work runs on two tracks, and safety planning comes first. The outlook is better than BPD’s old reputation suggests. In a 10-year study of 175 patients with BPD, 85% remitted and only 12% relapsed, though social functioning stayed impaired.⁴⁸ In the McLean 16-year follow-up, 78% to 99% achieved sustained symptomatic remission, but only 40% to 60% achieved recovery with good social and vocational functioning.⁴⁹ Symptoms often ease. Building a life takes longer, and that is where therapy keeps earning its place.

Strengths, without the romance

People with BPD are extremely sensitive to perceived interpersonal slights,³ but sensitivity is not accuracy: the facial-emotion meta-analysis found them less accurate than controls at recognizing anger, disgust and neutral faces.⁴⁷ Learning to check that alertness against what is actually happening is much of what therapy does. The creativity link has better data. A Swedish registry study of more than 1.1 million patients found bipolar disorder was the only diagnosis overrepresented in creative professions overall, and relatives were overrepresented too,⁵⁰ though a critical review noted that much of the belief rests on biographies of famous artists and that the mechanisms are barely tested.⁵¹ For the adaptability claim I found no evidence, so it is gone.

If you are trying to work out which of these describes you or someone you love, start with the timeline and a careful evaluation, not a questionnaire score. Taproot offers dialectical behavior therapy and therapy for depression and other mood disorders in Hoover, and therapy for either condition works best when it is coordinated with whoever prescribes. When you are ready, the contact page is the place to start.

References

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
2. Paris, J., & Black, D. W. (2015). Borderline personality disorder and bipolar disorder: What is the difference and why does it matter? Journal of Nervous and Mental Disease, 203(1), 3–7. https://doi.org/10.1097/NMD.0000000000000225
3. Gunderson, J. G., Herpertz, S. C., Skodol, A. E., Torgersen, S., & Zanarini, M. C. (2018). Borderline personality disorder. Nature Reviews Disease Primers, 4, Article 18029. https://doi.org/10.1038/nrdp.2018.29
4. Stoffers-Winterling, J. M., Storebø, O. J., Pereira Ribeiro, J., Kongerslev, M. T., Völlm, B. A., Mattivi, J. T., Faltinsen, E., Todorovac, A., Jørgensen, M. S., Callesen, H. E., Sales, C. P., Schaug, J. P., Simonsen, E., & Lieb, K. (2022). Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 2022(11), Article CD012956. https://doi.org/10.1002/14651858.CD012956.pub2
5. Leichsenring, F., Fonagy, P., Heim, N., Kernberg, O. F., Leweke, F., Luyten, P., Salzer, S., Spitzer, C., & Steinert, C. (2024). Borderline personality disorder: A comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World Psychiatry, 23(1), 4–25. https://doi.org/10.1002/wps.21156
6. Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O’Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., … Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609
7. Henry, C., Mitropoulou, V., New, A. S., Koenigsberg, H. W., Silverman, J., & Siever, L. J. (2001). Affective instability and impulsivity in borderline personality and bipolar II disorders: Similarities and differences. Journal of Psychiatric Research, 35(6), 307–312. https://doi.org/10.1016/S0022-3956(01)00038-3
8. Reich, D. B., Zanarini, M. C., & Fitzmaurice, G. (2012). Affective lability in bipolar disorder and borderline personality disorder. Comprehensive Psychiatry, 53(3), 230–237. https://doi.org/10.1016/j.comppsych.2011.04.003
9. Malkoff-Schwartz, S., Frank, E., Anderson, B., Sherrill, J. T., Siegel, L., Patterson, D., & Kupfer, D. J. (1998). Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: A preliminary investigation. Archives of General Psychiatry, 55(8), 702–707. https://doi.org/10.1001/archpsyc.55.8.702
10. Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., Reilly-Harrington, N. A., Nierenberg, A. A., Sachs, G. S., & Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). American Journal of Psychiatry, 163(2), 217–224. https://doi.org/10.1176/appi.ajp.163.2.217
11. Ghaemi, S. N., Dalley, S., Catania, C., & Barroilhet, S. (2014). Bipolar or borderline: A clinical overview. Acta Psychiatrica Scandinavica, 130(2), 99–108. https://doi.org/10.1111/acps.12257
12. McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., & Cardno, A. (2003). The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry, 60(5), 497–502. https://doi.org/10.1001/archpsyc.60.5.497
13. Stern, A. (1938). Psychoanalytic investigation of and therapy in the border line group of neuroses. The Psychoanalytic Quarterly, 7(4), 467–489. https://doi.org/10.1080/21674086.1938.11925367
14. Kernberg, O. (1967). Borderline personality organization. Journal of the American Psychoanalytic Association, 15(3), 641–685. https://doi.org/10.1177/000306516701500309
15. Gunderson, J. G., & Singer, M. T. (1975). Defining borderline patients: An overview. American Journal of Psychiatry, 132(1), 1–10. https://doi.org/10.1176/ajp.132.1.1
16. Akiskal, H. S. (2004). Demystifying borderline personality: Critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatrica Scandinavica, 110(6), 401–407. https://doi.org/10.1111/j.1600-0447.2004.00461.x
17. Paris, J. (2004). Borderline or bipolar? Distinguishing borderline personality disorder from bipolar spectrum disorders. Harvard Review of Psychiatry, 12(3), 140–145. https://doi.org/10.1080/10673220490472373
18. Zimmerman, M., & Morgan, T. A. (2013). The relationship between borderline personality disorder and bipolar disorder. Dialogues in Clinical Neuroscience, 15(2), 155–169. https://doi.org/10.31887/DCNS.2013.15.2/mzimmerman
19. Zimmerman, M., Ruggero, C. J., Chelminski, I., & Young, D. (2008). Is bipolar disorder overdiagnosed? Journal of Clinical Psychiatry, 69(6), 935–940. https://doi.org/10.4088/JCP.v69n0608
20. Ruggero, C. J., Zimmerman, M., Chelminski, I., & Young, D. (2010). Borderline personality disorder and the misdiagnosis of bipolar disorder. Journal of Psychiatric Research, 44(6), 405–408. https://doi.org/10.1016/j.jpsychires.2009.09.011
21. Skodol, A. E., & Bender, D. S. (2003). Why are women diagnosed borderline more than men? Psychiatric Quarterly, 74(4), 349–360. https://doi.org/10.1023/A:1026087410516
22. Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. A., Pulay, A. J., Pickering, R. P., & Ruan, W. J. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 69(4), 533–545. https://doi.org/10.4088/JCP.v69n0404
23. Fornaro, M., Orsolini, L., Marini, S., De Berardis, D., Perna, G., Valchera, A., Ganança, L., Solmi, M., Veronese, N., & Stubbs, B. (2016). The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. Journal of Affective Disorders, 195, 105–118. https://doi.org/10.1016/j.jad.2016.01.040
24. Temes, C. M., Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini, M. C. (2019). Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up. Journal of Clinical Psychiatry, 80(1), Article 18m12436. https://doi.org/10.4088/JCP.18m12436
25. Distel, M. A., Trull, T. J., Derom, C. A., Thiery, E. W., Grimmer, M. A., Martin, N. G., Willemsen, G., & Boomsma, D. I. (2008). Heritability of borderline personality disorder features is similar across three countries. Psychological Medicine, 38(9), 1219–1229. https://doi.org/10.1017/S0033291707002024
26. Witt, S. H., Streit, F., Jungkunz, M., Frank, J., Awasthi, S., Reinbold, C. S., Treutlein, J., Degenhardt, F., Forstner, A. J., Heilmann-Heimbach, S., Dietl, L., Schwarze, C. E., Schendel, D., Strohmaier, J., Abdellaoui, A., Adolfsson, R., Air, T. M., Akil, H., Alda, M., … Rietschel, M. (2017). Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry, 7(6), Article e1155. https://doi.org/10.1038/tp.2017.115
27. Porter, C., Palmier-Claus, J., Branitsky, A., Mansell, W., Warwick, H., & Varese, F. (2020). Childhood adversity and borderline personality disorder: A meta-analysis. Acta Psychiatrica Scandinavica, 141(1), 6–20. https://doi.org/10.1111/acps.13118
28. Palmier-Claus, J. E., Berry, K., Bucci, S., Mansell, W., & Varese, F. (2016). Relationship between childhood adversity and bipolar affective disorder: Systematic review and meta-analysis. British Journal of Psychiatry, 209(6), 454–459. https://doi.org/10.1192/bjp.bp.115.179655
29. Agrawal, H. R., Gunderson, J., Holmes, B. M., & Lyons-Ruth, K. (2004). Attachment studies with borderline patients: A review. Harvard Review of Psychiatry, 12(2), 94–104. https://doi.org/10.1080/10673220490447218
30. Schulze, L., Schmahl, C., & Niedtfeld, I. (2016). Neural correlates of disturbed emotion processing in borderline personality disorder: A multimodal meta-analysis. Biological Psychiatry, 79(2), 97–106. https://doi.org/10.1016/j.biopsych.2015.03.027
31. Hibar, D. P., Westlye, L. T., van Erp, T. G., Rasmussen, J., Leonardo, C. D., Faskowitz, J., Haukvik, U. K., Hartberg, C. B., Doan, N. T., Agartz, I., Dale, A. M., Gruber, O., Krämer, B., Trost, S., Liberg, B., Abé, C., Ekman, C. J., Ingvar, M., Landén, M., … Andreassen, O. A. (2016). Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry, 21(12), 1710–1716. https://doi.org/10.1038/mp.2015.227
32. Abi-Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., Sanacora, G., Veenstra-VanderWeele, J., & Krystal, J. H. (2023). Candidate biomarkers in psychiatric disorders: State of the field. World Psychiatry, 22(2), 236–262. https://doi.org/10.1002/wps.21078
33. Boland, C., Jalihal, V., Organ, C., Oak, K., McLean, B., Laugharne, R., Woldman, W., Beck, R., & Shankar, R. (2021). EEG markers in emotionally unstable personality disorder: A possible outcome measure for neurofeedback. A narrative review. Clinical EEG and Neuroscience, 52(4), 254–273. https://doi.org/10.1177/1550059420937948
34. Paret, C., Jindrová, M., Kleindienst, N., Eck, J., Breman, H., Lührs, M., Barth, B., Ethofer, T., Fallgatter, A. J., Goebel, R., Hoell, A., Lockhofen, D., Reinhold, A. S., Maier, S., Matthies, S., Mulert, C., Schönholz, C., van Elst, L. T., & Schmahl, C. (2025). A randomised controlled trial of amygdala fMRI-neurofeedback versus sham-feedback in borderline-personality disorder: Systematic literature review and introduction to the BrainSTEADy trial. BMC Psychiatry, 25, Article 687. https://doi.org/10.1186/s12888-025-07000-1
35. Thibault, R. T., & Raz, A. (2017). The psychology of neurofeedback: Clinical intervention even if applied placebo. American Psychologist, 72(7), 679–688. https://doi.org/10.1037/amp0000118
36. Linehan, M. M., Armstrong, H. E., Suarez, A., Allmon, D., & Heard, H. L. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48(12), 1060–1064. https://doi.org/10.1001/archpsyc.1991.01810360024003
37. Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63(7), 757–766. https://doi.org/10.1001/archpsyc.63.7.757
38. Bateman, A., & Fonagy, P. (1999). Effectiveness of partial hospitalization in the treatment of borderline personality disorder: A randomized controlled trial. American Journal of Psychiatry, 156(10), 1563–1569. https://doi.org/10.1176/ajp.156.10.1563
39. Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T., Mattivi, J. T., Jørgensen, M. S., Faltinsen, E., Todorovac, A., Sales, C. P., Callesen, H. E., Lieb, K., & Simonsen, E. (2020). Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 2020(5), Article CD012955. https://doi.org/10.1002/14651858.CD012955.pub2
40. Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers, P. (2017). Efficacy of psychotherapies for borderline personality disorder: A systematic review and meta-analysis. JAMA Psychiatry, 74(4), 319–328. https://doi.org/10.1001/jamapsychiatry.2016.4287
41. McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner, D. L. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166(12), 1365–1374. https://doi.org/10.1176/appi.ajp.2009.09010039
42. Crawford, M. J., Sanatinia, R., Barrett, B., Cunningham, G., Dale, O., Ganguli, P., Lawrence-Smith, G., Leeson, V., Lemonsky, F., Lykomitrou, G., Montgomery, A. A., Morriss, R., Munjiza, J., Paton, C., Skorodzien, I., Singh, V., Tan, W., Tyrer, P., Reilly, J. G., & LABILE study team. (2018). The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: A randomized placebo-controlled trial. American Journal of Psychiatry, 175(8), 756–764. https://doi.org/10.1176/appi.ajp.2018.17091006
43. Miklowitz, D. J., Efthimiou, O., Furukawa, T. A., Scott, J., McLaren, R., Geddes, J. R., & Cipriani, A. (2021). Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiatry, 78(2), 141–150. https://doi.org/10.1001/jamapsychiatry.2020.2993
44. Bohus, M., Kleindienst, N., Hahn, C., Müller-Engelmann, M., Ludäscher, P., Steil, R., Fydrich, T., Kuehner, C., Resick, P. A., Stiglmayr, C., Schmahl, C., & Priebe, K. (2020). Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: A randomized clinical trial. JAMA Psychiatry, 77(12), 1235–1245. https://doi.org/10.1001/jamapsychiatry.2020.2148
45. Novo, P., Landin-Romero, R., Radua, J., Vicens, V., Fernandez, I., Garcia, F., Pomarol-Clotet, E., McKenna, P. J., Shapiro, F., & Amann, B. L. (2014). Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: A randomized, controlled pilot-study. Psychiatry Research, 219(1), 122–128. https://doi.org/10.1016/j.psychres.2014.05.012
46. Francis, B., Fino, E., & Heym, N. (2026). A systematic review of dialectical behaviour therapy, mentalisation-based treatment and internal family systems therapy for borderline personality disorder with comorbid depression and/or anxiety. Journal of Psychiatric Research, 194, 221–232. https://doi.org/10.1016/j.jpsychires.2026.01.002
47. Daros, A. R., Zakzanis, K. K., & Ruocco, A. C. (2013). Facial emotion recognition in borderline personality disorder. Psychological Medicine, 43(9), 1953–1963. https://doi.org/10.1017/S0033291712002607
48. Gunderson, J. G., Stout, R. L., McGlashan, T. H., Shea, M. T., Morey, L. C., Grilo, C. M., Zanarini, M. C., Yen, S., Markowitz, J. C., Sanislow, C., Ansell, E., Pinto, A., & Skodol, A. E. (2011). Ten-year course of borderline personality disorder: Psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Archives of General Psychiatry, 68(8), 827–837. https://doi.org/10.1001/archgenpsychiatry.2011.37
49. Zanarini, M. C., Frankenburg, F. R., Reich, D. B., & Fitzmaurice, G. (2012). Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: A 16-year prospective follow-up study. American Journal of Psychiatry, 169(5), 476–483. https://doi.org/10.1176/appi.ajp.2011.11101550
50. Kyaga, S., Landén, M., Boman, M., Hultman, C. M., Långström, N., & Lichtenstein, P. (2013). Mental illness, suicide and creativity: 40-year prospective total population study. Journal of Psychiatric Research, 47(1), 83–90. https://doi.org/10.1016/j.jpsychires.2012.09.010
51. Johnson, S. L., Murray, G., Fredrickson, B., Youngstrom, E. A., Hinshaw, S., Bass, J. M., Deckersbach, T., Schooler, J., & Salloum, I. (2012). Creativity and bipolar disorder: Touched by fire or burning with questions? Clinical Psychology Review, 32(1), 1–12. https://doi.org/10.1016/j.cpr.2011.10.001